N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells - PubMed
- PMID: 427742
N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells
D L Dexter et al. Cancer Res. 1979 Mar.
Abstract
Human colon carcinoma cell lines established in this laboratory were treated in vitro with N,N-dimethylformamide. This polar solvent caused morphological changes in the cells as well as alterations in their growth properties. Untreated cells had cloning efficiencies of up to 77% in soft agar; treatment with N,N-dimethylformamide resulted in a complete loss of clonogenicity in semisolid medium. Growth in the presence of the polar solvent also effected a marked reduction in the tumorigenicity of the cells. Ten of ten nude mice that received a s.c. inoculum of 1 X 10(6) untreated cells developed tumors histologically similar to colonic adenocarcinomas in 10 to 14 days, whereas nine of ten nude mice inoculated with 1 X 10(6) treated cells have shown no sign of tumor 3 to 6 months postinjection. Removal of the polar solvent from the culture medium was accompanied by the reappearance of tumorigenicity and the original cell culture characteristics. Therefore, it appears that N,N-dimethylformamide can reversibly effect the reversion of cultured human colon carcinoma cells to less malignant cell types.
Similar articles
-
Inhibition of the growth of human colon cancer xenografts by polar solvents.
Dexter DL, Spremulli EN, Matook GM, Diamond I, Calabresi P. Dexter DL, et al. Cancer Res. 1982 Dec;42(12):5018-22. Cancer Res. 1982. PMID: 7139607
-
Heterogeneity of human colon carcinoma.
Brattain MG, Levine AE, Chakrabarty S, Yeoman LC, Willson JK, Long B. Brattain MG, et al. Cancer Metastasis Rev. 1984;3(3):177-91. doi: 10.1007/BF00048384. Cancer Metastasis Rev. 1984. PMID: 6437669 Review.
-
Polar solvents: a novel class of antineoplastic agents.
Spremulli EN, Dexter DL. Spremulli EN, et al. J Clin Oncol. 1984 Mar;2(3):227-41. doi: 10.1200/JCO.1984.2.3.227. J Clin Oncol. 1984. PMID: 6321692 Review.
Cited by
-
p53 mutations in colorectal cancer.
Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP. Rodrigues NR, et al. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7555-9. doi: 10.1073/pnas.87.19.7555. Proc Natl Acad Sci U S A. 1990. PMID: 1699228 Free PMC article.
-
Jessup JM, Petrick AT, Toth CA, Ford R, Meterissian S, O'Hara CJ, Steele G Jr, Thomas P. Jessup JM, et al. Br J Cancer. 1993 Mar;67(3):464-70. doi: 10.1038/bjc.1993.88. Br J Cancer. 1993. PMID: 8439497 Free PMC article.
-
Browning MJ, Krausa P, Rowan A, Bicknell DC, Bodmer JG, Bodmer WF. Browning MJ, et al. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2842-5. doi: 10.1073/pnas.90.7.2842. Proc Natl Acad Sci U S A. 1993. PMID: 8464898 Free PMC article.
-
Calcium- and cyclic AMP-dependent chloride secretion in human colonic epithelia.
Cuthbert AW, Egléme C, Greenwood H, Hickman ME, Kirkland SC, MacVinish LJ. Cuthbert AW, et al. Br J Pharmacol. 1987 Jul;91(3):503-15. doi: 10.1111/j.1476-5381.1987.tb11243.x. Br J Pharmacol. 1987. PMID: 3038239 Free PMC article.
-
Arancia G, Leonetti C, Malorni W, Greco C, Formisano G, Marangolo M, Zupi G. Arancia G, et al. J Cancer Res Clin Oncol. 1991;117(4):351-8. doi: 10.1007/BF01630719. J Cancer Res Clin Oncol. 1991. PMID: 2066356
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials